Alejandro Olivé-Marqués
Impact in
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- Atherosclerosis and Cardiovascular Diseases
- T-cell and B-cell Immunology
Papers in
- Rheumatology 14
- Systemic Lupus Erythematosus Research 13
-
- Atherosclerosis and Cardiovascular Diseases 3
Alejandro Olivé-Marqués
21 papers receiving 555 citations
Peers
Comparison fields: 5 of 48
- Rheumatology 398
- Immunology 124
- Pulmonary and Respiratory Medicine 94
- Hematology 31
- Nephrology 16
Countries citing papers authored by Alejandro Olivé-Marqués
This map shows the geographic impact of Alejandro Olivé-Marqués's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Olivé-Marqués with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Olivé-Marqués more than expected).
Fields of papers citing papers by Alejandro Olivé-Marqués
This network shows the impact of papers produced by Alejandro Olivé-Marqués. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Olivé-Marqués. The network helps show where Alejandro Olivé-Marqués may publish in the future.
Co-authors
The 2 scholars most cited alongside Alejandro Olivé-Marqués, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 130 | |
| 2 | 2015 | 92 | |
| 3 | 2019 | 82 | |
| 4 | Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. | 2016 | 47 |
| 5 | 2015 | 45 | |
| 6 | 2020 | 36 | |
| 7 | Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). | 2018 | 26 |
| 8 | Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. | 2020 | 26 |
| 9 | 2014 | 24 | |
| 10 | 2018 | 17 | |
| 11 | 2019 | 15 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2013 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 2 | |
| 20 | Lupus Impact Tracker Responds to Changes in Low Disease Activity and Remission Outcomes in a Large Spanish Lupus Registry Cohort | 2018 | 1 |
About Alejandro Olivé-Marqués
Alejandro Olivé-Marqués is a scholar working on Rheumatology, Immunology, Hepatology, Emergency Medicine and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 577 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (13 papers), Vasculitis and related conditions (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Liver Diseases and Immunity (2 papers), Infectious Diseases and Tuberculosis (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Rheumatology (398 citations), Immunology (124 citations), Pulmonary and Respiratory Medicine (94 citations), Hematology (31 citations) and Nephrology (16 citations). Alejandro Olivé-Marqués has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Melania Martínez‐Morillo and Lourdes Mateo. Their work appears in journals such as Seminars in Arthritis and Rheumatism, Medicine, Lara D. Veeken, Lupus and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.